Review

Multiple sclerosis; a disease of reproductive-aged women and the dilemma involving contraceptive methods

10.5152/jtgga.2015.15186

  • Esengül Türkyılmaz
  • Melahat Yıldırım
  • Ayşe Filiz Yavuz Avşar

Received Date: 01.10.2014 Accepted Date: 08.02.2015 J Turk Ger Gynecol Assoc 2015;16(1):49-53 PMID: 25788851

Multiple sclerosis (MS) is an autoimmune disorder characterized by chronic inflammation in the central nerves system. Because the disease predominantly affects women of reproductive ages, having knowledge about contraception options for MS patients can make clinicians provide better counseling. Although most contraceptive methods are generally accepted as safe and effective in MS patients, recent studies have raised questions about their potential adverse effects on the disease. The use of contraceptive methods to avoid unintended pregnancies is crucial in MS patients, particularly during the relapse phase of the disease or the time when the disease is not completely under control. This review investigates the contraception options and their effects on female MS patients. Providing appropriate contraception options to multiple sclerosis patients will be one of the most challenging issues for clinicians to deal with. Recent studies have raised questions that the use of hormonal contraceptives may at least partly contribute to the rise in incidence of MS in women. This review investigates the contraception options and their effects on female MS patients.

Keywords: Multiple Sclerosis, contraception, contraceptives